Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
2013 2
2017 4
2018 3
2019 3
2020 3
2021 3
2022 7
2023 2
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.
Wang DY, Salem JE, Cohen JV, Chandra S, Menzer C, Ye F, Zhao S, Das S, Beckermann KE, Ha L, Rathmell WK, Ancell KK, Balko JM, Bowman C, Davis EJ, Chism DD, Horn L, Long GV, Carlino MS, Lebrun-Vignes B, Eroglu Z, Hassel JC, Menzies AM, Sosman JA, Sullivan RJ, Moslehi JJ, Johnson DB. Wang DY, et al. Among authors: menzer c. JAMA Oncol. 2018 Dec 1;4(12):1721-1728. doi: 10.1001/jamaoncol.2018.3923. JAMA Oncol. 2018. PMID: 30242316 Free PMC article.
Inpatient Management of Mucocutaneous GVHD.
Vaidya T, Menzer C, Ponce DM, Markova A. Vaidya T, et al. Among authors: menzer c. Curr Dermatol Rep. 2019 Dec;8(4):258-278. doi: 10.1007/s13671-019-00280-3. Epub 2019 Nov 11. Curr Dermatol Rep. 2019. PMID: 33312761 Free PMC article.
Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patients.
Hansen-Abeck I, Geidel G, Abeck F, Kött J, Cankaya R, Dobos G, Mitteldorf C, Nicolay JP, Albrecht JD, Menzer C, Livingstone E, Mengoni M, Braun AD, Wobser M, Klemke CD, Tratzmiller S, Assaf C, Terheyden P, Klespe KC, Schneider SW, Booken N. Hansen-Abeck I, et al. Among authors: menzer c. J Dtsch Dermatol Ges. 2024 Nov;22(11):1489-1497. doi: 10.1111/ddg.15511. Epub 2024 Oct 2. J Dtsch Dermatol Ges. 2024. PMID: 39358932
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
Livingstone E, Zimmer L, Hassel JC, Fluck M, Eigentler TK, Loquai C, Haferkamp S, Gutzmer R, Meier F, Mohr P, Hauschild A, Schilling B, Menzer C, Kiecker F, Dippel E, Roesch A, Ziemer M, Conrad B, Körner S, Windemuth-Kieselbach C, Schwarz L, Garbe C, Becker JC, Schadendorf D; Dermatologic Cooperative Oncology Group. Livingstone E, et al. Among authors: menzer c. Lancet. 2022 Oct 1;400(10358):1117-1129. doi: 10.1016/S0140-6736(22)01654-3. Epub 2022 Sep 10. Lancet. 2022. PMID: 36099927 Clinical Trial.
Laser therapy as a treatment for chronic radiation fibrosis.
Wilson B, Shah R, Menzer C, Aleisa A, Rossi A. Wilson B, et al. Among authors: menzer c. Lasers Surg Med. 2023 Jan;55(1):82-88. doi: 10.1002/lsm.23617. Epub 2022 Nov 9. Lasers Surg Med. 2023. PMID: 36349748 Free PMC article.
Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database.
Menzer C, Dugas-Breit S, Dugas M, Blank CU, Groen EJ, Reijers I, Schlaak M, Eckardt J, Suijkerbuijk KPM, Zimmer L, Johnson DB, Franklin C, Meiss F, Schilling B, Meier F, Gutzmer R, Thoms KM, Haalck T, Müller M, Kopp-Schneider A, Carlino MS, Long GV, Menzies AM, van der Veldt AAM, de Groot JWB, Eigentler T, Stevense-den Boer M, Pföhler C, Herbschleb K, Hassel JC. Menzer C, et al. Eur J Cancer. 2025 Oct 1;228:115703. doi: 10.1016/j.ejca.2025.115703. Epub 2025 Aug 9. Eur J Cancer. 2025. PMID: 40850313
31 results